6/26/2025

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Source: Yahoo

6/25/2025

Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors

Source: MarketWatch

6/24/2025

Despite Revvity’s underperformance relative to the Dow over the past year, Wall Street analysts are moderately optimistic about its prospects.

Source: Yahoo

6/23/2025

Key Insights Labcorp Holdings' estimated fair value is US$415 based on 2 Stage Free Cash Flow to Equity Labcorp...

Source: Yahoo

6/23/2025

Labcorp’s first quarter saw steady execution in a complex environment, with results that prompted a positive market response. Management pointed to volume recovery in its Diagnostics Laboratories segment, following early quarter weather disruptions, and highlighted momentum from recent acquisitions such as Invitae. CEO Adam Schechter credited “strong managed care access and our payer contracts” for supporting growth, while noting that operational efficiencies helped offset inflation in personnel

Source: Yahoo

6/19/2025

Key Takeaways ...

Source: Finnhub

6/18/2025

LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.

Source: Yahoo

6/18/2025

DURHAM, N.C., June 18, 2025--GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology

Source: Yahoo

6/18/2025

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Whole Health Solutions to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.

Source: Yahoo

6/18/2025

PreciseDx, the leading innovator behind PreciseBreast, a novel breast cancer diagnostic that is powered by OncoIntelligence, their proprietary AI-platform, today announced the successful closing of $11 million in funding and two key leadership hires. This latest round of funding was led by Eventide Asset Management ("Eventide"), Merck Global Health Innovation Fund and Philips Ventures and included Labcorp, Quest Diagnostics, GenHenn Capital Venture, along with other existing investors. This fund

Source: Yahoo

6/18/2025

Labcorp’s 14.6% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $259.45 per share. This run-up might have investors contemplating their next move.

Source: Yahoo

6/17/2025

Labcorp Holdings Inc. stock outperforms competitors despite losses on the day

Source: MarketWatch

6/17/2025

Seyfarth Synopsis: On June 5, 2025, the U.S. Supreme Court changed course and dismissed the writ of certiorari that it previously had granted in Laboratory Corporation of America Holdings v. Davis,...

Source: Finnhub

6/17/2025

Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and raised the 12-month price target to $283 from $270. The adjustment underscores the investment firm’s confidence in the company’s growth prospects as it also faces durable demand for […]

Source: Yahoo

6/16/2025

Labcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains

Source: MarketWatch

6/13/2025

Summary The U.S. Supreme Court last week declined to resolve a potentially landmark issue in class action law. In the closely watched case of Laboratory Corporation of America Holdings v. Davis, the...

Source: Finnhub

6/12/2025

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Onco

Source: Yahoo

6/11/2025

What You Need to Know ...

Source: Finnhub

6/11/2025

Source: SeekingAlpha

6/10/2025

Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains

Source: MarketWatch